Droxidopa

FDA Approved: * February 18, 2021
Pharm Company: * ZYDUS PHARMS USA INC
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Droxidopa Overview

Droxidopa (INN; trade name Northera; also known as L-DOPS, L-threo-dihydroxyphenylserine, L-threo-DOPS and SM-5688) is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine (noradrenaline).[1] Unlike norepinephrine, droxidopa is capable of crossing the protective blood–brain barrier (BBB).[1] Contents 1 Indications 2 History 2.1 Clinical trials 3 Pharmacology 4 Side effects 5 References 6 External links ...

Read more Droxidopa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Droxidopa

Recent Droxidopa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Droxidopa
  • Capsule: 100mg, 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Droxidopa: (31 results)

Showing the first 20, Sorted by National Drug Code
  • 0054-0532 Droxidopa 100 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0533 Droxidopa 200 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0534 Droxidopa 300 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0832-0720 Droxidopa 100 mg Oral Capsule by Upsher-smith Laboratories, LLC
  • 0832-0721 Droxidopa 200 mg Oral Capsule by Upsher-smith Laboratories, LLC
  • 0832-0722 Droxidopa 300 mg Oral Capsule by Upsher-smith Laboratories, LLC
  • 27241-199 Droxidopa 100 mg Oral Capsule by Ajanta Pharma Limited
  • 27241-200 Droxidopa 200 mg Oral Capsule by Ajanta Pharma Limited
  • 27241-201 Droxidopa 300 mg Oral Capsule by Ajanta Pharma Limited
  • 31722-010 Droxidopa 300 mg Oral Capsule by Camber Pharmaceuticals, Inc.
  • 50228-429 Droxidopa 100 mg Oral Capsule by Sciegen Pharmaceuticals Inc
  • 50228-430 Droxidopa 200 mg Oral Capsule by Sciegen Pharmaceuticals Inc
  • 50228-431 Droxidopa 300 mg Oral Capsule by Sciegen Pharmaceuticals Inc
  • 59651-375 Droxidopa 100 mg Oral Capsule by Aurobindo Pharma Limited
  • 59651-376 Droxidopa 200 mg Oral Capsule by Aurobindo Pharma Limited
  • 59651-377 Droxidopa 300 mg Oral Capsule by Aurobindo Pharma Limited
  • 63304-086 Droxidopa 100 ug/1 Oral Capsule by Sun Pharmaceutical Industries, Inc.
  • 63304-104 Droxidopa 200 ug/1 Oral Capsule by Sun Pharmaceutical Industries, Inc.
  • 63304-112 Droxidopa 300 ug/1 Oral Capsule by Sun Pharmaceutical Industries, Inc.
  • 67877-704 Droxidopa 100 mg Oral Capsule by Ascend Laboratories, LLC
  • 11 more results ...

Other drugs which contain Droxidopa or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA